208
Participants
Start Date
September 3, 2014
Primary Completion Date
December 15, 2015
Study Completion Date
October 11, 2016
Placebo
Participants will receive matching placebo.
Golimumab
Participants will receive 2mg/kg of intravenous infusions of golimumab .
Glendale
Mesa
La Palma
Granger
St Louis
Orchard Park
Salisbury
Middleburg Heights
Duncansville
Austin
Houston
Maroochydore
St. John's
Burlington
Trois-Rivières
Bad Doberan
Berlin
Erfurt
Hamburg
Planegg
Ratingen
Zerbst
Chihuahua City
Bydgoszcz
Bytom
Nadarzyn
Nowa Sól
Poznan
Warsaw
Moscow
Saint Petersburg
Saratov
Smolensk
Tver'
Ansan
Daegu
Gwangju
Seongdong-Gu
Seoul
Chernihiv
Dnipropetrovsk
Kyiv
Odesa
Vinnytsia
Zaporizhzhia
Janssen Research & Development, LLC
INDUSTRY